Biomarkers in acute aortic syndrome

Thoracic Aortic Diseases

Volumn , Issue , 2006, Pages 55-70

  Pepe, Guglielmina ^a   Giusti, Betti ^a   Porciani, Maria Cristina ^a   Yacoub, Magdi ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 63149193151     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-38309-3_5     Document Type: Chapter

References (119)

1. Abraham PA, Perejda AJ, Carnes WH, Uitto J (1982) Marfan syndrome. Demonstration of abnormal elastin in aorta. J Clin Invest 70:1245-1252.
2. Absi TS, Sundt TM, Tung WS, Moon M, Lee JK, Damiano RR Jr, Thompson RW (2003) Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg 126:344-357.
3. Aikawa M, Silvam PN, Kuro-o M et al (1993) Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 73:1000-1012.
4. Anagnostopoulos CE, Prabhakar MJS, Kittle CF (1972) Aortic dissections and dissecting aneurysms. Am J Cardiol 30:263-273.
5. Bautista L, Arenas I, Penuela A, Martinez LX (2002) Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol 55:882-887.
6. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1998) Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 77:31-37.
7. Bick RL (1994) Disseminated intravascular coagulation: objective laboratory diagnostic criteria and guidelines for management. Clin Lab Med 14:729-768.
8. Blankenship JC, Almquist AK (1989) Cardiovascular complications of thrombolytic therapy in patients with a mistaken diagnosis of acute myocardial infarction. J Am Coll Cardiol 14:1579-1582.
9. Bonderman D, Gharehbaghi-Schnell E, Wollenek G, Maurer G, Baumgartner H, Lang IM (1999) Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation 99:2138-2143.
10. Boyum J, Fellinger EK, Schmöker JD, Trombley L, McPart-land K, Ittleman FP, Howard AB (2004) Matrix metallo-proteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg 127:686-691.
11. Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, Giusti B, Pratesi C, Pulli R, Gensini GF, Abbate R, Pepe G (2000) High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vase Surg 32:531-536.
12. Butler J, Davies AH, Westaby S (1990) Streptokinase in acute aortic dissection. Br Med J 300:517-519.
13. Cattaneo M (1999) Hyperhomocyseinemia, atherosclerosis and thrombosis. Thromb Haemost 81:165-176.
14. Clark JM, Glagov S (1985) Transmural organization of the arterial media: the lamellar unit revisited. Arteriosclerosis 5:19-34.
15. Costantini V, Zacharski LR (1993) Fibrin and cancer. Thromb Haemost 69:406-414.
16. Danesh J, Whincup P, Walker M et al. (2001) Fibrin D-di-mer and coronary heart disease: prospective study and meta-analysis. Circulation 103:2323-2327.
17. De Sa M, Moshkovitz Y, Butany J, David TE (1999) Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the Ross procedure. J Thorac Cardiovasc Surg 118:588-594.
18. Dietz HC (1996) Molecular etiology, pathogenesis and diagnosis of the Marfan syndrome. Prog Pediatr Cardiol 5:159-166.
19. Dietz HC, Pyeritz RE (2001) Marfan syndrome and relate disorders. In: Scriver CR (ed) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 5287-5312.
20. Dobrin PB (1988) Mechanics of normal and diseased blood vessels. Ann Vase Surg 2:283-294.
21. Eggebrecht H, Baumgart D, Schmermund A, Herold U, Hunold P, Jakob H, Erbel R (2003) Penetrating atherosclerotic ulcer of the aorta: treatment by endovascular stent-graft placement. Curr Opin Cardiol 18:431-435.
22. Eggebrecht H, Naber CK, Bruch C et al. (2004) Value of plasma fibrin D-dimers for detection of acute aortic dissection. J Am Coll Cardiol 44:804-809.
23. Elmore JR, Keister BF, Franklin DP, Youkey JR, Carey DJ (1998) Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vase Surg 12: 221-228.
24. Erbel R, Oelert H, Meyer J et al. (1993) Effect of medical and surgical therapy on aortic dissection evaluated by transesophageal echocardiography: implications for prognosis and therapy. Circulation 87:1604-1615.
25. Erbel R, Alfonso F, Boileau C et al. (2001) Diagnosis and management of aortic dissection. Eur Heart J 22:1642-1681.
26. Erdheim J (1929) Medionecrosis aortae idiopathica. Vir-chows Arch 273:454-479.
27. Faxon DP, Fuster V, Libby P et al. (2004) Atherosclerotic vascular disease conference: writing group III: pathophysiology. Circulation 109:2617-2625.
28. Folsom AR, Aleksic N, Park E et al. (2001) Prospective study of fibrinolytic factors and incident coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vase Biol 21:611-617.
29. Francke U, Berg MA, Tynan K et al. (1995) A Glyll27Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. Am J Hum Genet 56:1287-1296.
30. Furthmayr H, Francke U (1997) Ascending aortic aneurysm with or without features of Marfan syndrome and other fibrillinopathies: new insights. Semin Thorac Cardiovasc Surg 9:191-205.
31. Girelli D, Friso S, Trabetti E et al. (1998) Methylenetetra-hydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood 91:4158-4163.
32. Giusti B, Porciani MC, Brunelli T, Evangelist! L, Fedi S, Gensini GF, Abbate R, Sani G, Yacoub M, Pepe G (2003) Phenotypic variability of cardiovascular manifestations in Marfan Syndrome. Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism. Eur Heart J 24:2038-2045.
33. Goldhaber SZ, Simons GR, Elliott CG et al. (1993) Quantitative plasma D-dimer levels among patients undergoing pulmonary angiography for suspected pulmonary embolism. JAMA 270:2819-2822.
34. Hasham SN, Willing MC, Guo DC et al. (2003) Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation 107:3184-3190.
35. Henderson EL, Gang YJ, Sukhova GK, Whittemore AD, Knox J, Libby P (1999) Deathof smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99:96-104.
36. Hirschfield GM, Pepys MB (2003) C-reactive protein and cardiovascular disease: new insights from an old molecule. Q J Med 96:793-807.
37. Homocysteine Studies Collaboration (2002) J Am Med Assoc 288:2015-2022.
38. Hormuzdi SG, Penttinen R, Jaenisch R, Bornstein P (1998) A gene-targeting approach identifies a function for the first intron in expression of the alphal(I) collagen gene. Mol Cell Biol 18:3368-3375.
39. Ikonomidis JS, Gibson WC, Butler JE, McClister DM, Swe-terlitsch SE, Thompson RP, Mukherjee R, Spinale FG (2004) Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms. Circulation 110 (11 Suppl l):II268-273.
40. Isotalo PA, Guindi MM, Bedard P, Brais MP, Veinot JP (1999) Aortic dissection: a rare complication of osteogen esis imperfecta. Can J Cardiol 15:1139-1142.
41. Jin P, Warren ST (2003) New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Bio-chem Sei 28:152-158.
42. Kakko S, Raisanen T, Tamminen M et al. (2003) Candidate locus analysis of familial ascending aortic aneurysms and dissections confirms the linkage to the chromosome 5ql3-14 in Finnish families. J Thorac Cardiovasc Surg 126:106-113.
43. Kaschina E, Stoll M, Sommerfeld M, Steckelings UM, Kreutz R, Unger T (2004) Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis. Physiol Genomics 19:41-49.
44. Katoh H, Suzuki T, Hiroi Y et al. (1995) Diagnosis of aortic dissection by immunoassay for circulating smooth muscle myosin. Lancet 345:191-192.
45. Katoh H, Suzuki T, Yokomori K et al. (1995) A novel immunoassay of smooth muscle myosin heavy chain in serum. J Immunol Methods 185:57-63.
46. Keen RR, Dobrin PB (2000) Development of aneurysm. Landes Bioscience, Georgetown, TX.
47. Khoury NE, Borzak S, Gokli A et al. (1996) "Inadvertent" thrombolytic administration in patients without myocardial infarction: clinical features and outcome. Ann Emerg Med 28:553-554.
48. Kielty CM (2005) Applying elastic fibre biology in vascular tissue engineering. Philos Trans R Soc Lond Ser B (Theme issue): Engineering the heart.
49. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG (2002) MTHFR 677C-, T polymorphism and risk of coronary heart disease: a meta-analysis. J Am Med Assoc 288:2023-2031.
50. Koch A, Kunkel S, Pearce W, Shah M, Parikh D, Evanoff H, Haines GK, Burdick MD, Strieter RM (1993) Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic anurysms. Am J Pathol 142:1423-1431.
51. Koenig W, Rothenbacher D, Hoffmeister A et al. (2001) Plasma fibrin D-dimer levels and risk of stable coronary artery disease: Results of a large case-control study. Arte-rioscler Thromb Vase Biol 21:1701-1705.
52. Korkko J, Kaitila I, Lonnqvist L, Peltonen L, Ala-Kokko L (2002) Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions. J Med Genet 39:34-41.
53. Koulhas GJ, Ravichandran P, Korkolis DP, Rimm DL, Elef-teriades JA (2004) Increased tissue microarray matrix me-talloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 78:2106-2111.
54. Kuivaniemi H, Tromp G, Bergfeld WF, Kay M, Helm TN (1995) Ehlers-Danlos syndrome type IV: a single base substitution of the last nucleotide of exon 34 in COL3A1 leads to exon skipping. J Invest Dermatol 105:352-356.
55. Kuro-o M, Nagai R, Tsuchimochi H et al. (1989) Develop-mentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem 264:18272-18275.
56. Lesauskaite V, Tanganelli P, Sassi C, Neri E, Diciolla F, Iva-noviene L et al. (2001) Smooth muscle cells of the media in the dilative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metal-loproteinases, and their inhibitors. Hum Pathol 32:1003-1011.
57. Loeys B, De Backer J, Van Acker P, Wettinck K, Pals G, Nuytinck L, Coucke P, De Paepe A (2004) Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome. Hum Mutat 24: MO-MO.
58. Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW (1997) Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 150:993-1007.
59. Makita S, Ohira A, Tachieda R et al. (2000) Behavior of C-reactive protein levels in medically treated aortic dissection and intramural hematoma. Am J Cardiol 86:242-244.
60. Malfait F, Coucke P, Symoens S et al. (2005) The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients. Hum Mutat 25:28-37.
61. Mao JR, Taylor G, Dean WB et al. (2002) Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet 30:421-425.
62. Marsalese DL, Moodie DS, Lytle BW, Cosgrove DM, Ratliff NB, Goormastic M, Kovacs A (1990) Cystic medial necrosis of the aorta in patients without Marfan's syndrome: surgical outcome and long-term follow-up. J Am Coll Cardiol 16:68-73.
63. Miano JM, Cserjesi P, Ligon KL et al. (1994) Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res 75:803-812.
64. Milewicz DM, Michael K, Fisher N, Coselli JS, Markello T, Biddinger A (1996) Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation 94:2708-2711.
65. Miller MJ, Geffner ME, Lippe BM et al. (1983) Echocardiography reveals a high incidence of bicuspid aortic valve in Turner syndrome. J Pediatr 102:47-50.
66. Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Claustres M, Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C, Kajii T, Jondeau G, Ohta T, Kishino T, Furukawa Y, Nakamura Y, Niikawa N, Boileau C, Matsumoto N (2004) Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36:855-860.
67. Muller BT, Modlich O, Prisack HB, et al. (2002) Gene expression profiles in the acutely dissected human aorta. Eur J Vase Endovasc Surg 24:356-364.
68. Murray CA, Edwards JE (1973) Spontaneous laceration of ascending aorta. Circulation 47:848-858.
69. Nagai R, Larson DM, Periasamy M (1988) Characterization of a mammalian smooth muscle myosin heavy chain cDNA clone and its expression in various smooth muscle types. Proc Natl Acad Sei USA 85:1047:1051.
70. Nagai R, Kuro-o M, Babij P, Periasamy M (1989) Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem 264:9734-9737.
71. Nakashima Y, Sueishi K (1992) Alterations of elastic architecture in the lathyritic rat aorta implies the pathogenesis of aortic dissecting aneurysm. Am J Pathol 140:959-969.
72. Nakashima Y, Shiokawa Y, Sueishi K (1990) Alterations of elastic architecture in human aortic dissecting aneurysm. Lab Invest 62:751-760.
73. Nataatmadja M, West M, West J, Summers K, Walker P, Nagata M, Watanabe T. (2003) Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 108 (Suppl l):II329-334.
74. Neumann RE, Logan MA (1950) The determination of collagen and elastin in tissues. J Biol Chem 186:549-556.
75. Niwa K, Perloff JK, Bhuta SM, Laks H, Drinkwater DC, Child JS, Miner PD (2001) Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 103:393-400.
76. Nuenninghoff DM, Warrington KJ, Matteson EL (2003) Concomitant giant cell aortitis, thoracic aortic aneurysm, and aortic arch syndrome: occurrence in a patient and significance. Arthritis Rheum 49:858-861.
77. Palinski W (2004) Aneurysms: leukotrienes weaken aorta from the outside. Nat Med 10:896-898.
78. Pepin M, Schwarze U, Superti-Furga A, Byers PH (2000) Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 342:673-680.
79. Powell JT, Vine N, Crossman M (1992) On the accumulation of D-aspartate in elastin and other proteins of the ageing aorta. Arteriosclerosis 97:201-208.
80. Prisco D, Antonucci E, Marcucci R, Pepe G (2000) D-di-mers in the year 2000: current data and new perspectives. Ann Ital Med Int 15:267-272.
81. Pyeritz RE (2003) Express yourself-but consider the consequences. J Thorac Cardiovasc Surg 126:334-336.
82. Rahkonen O, Su M, Hakovirta H et al. (2004) Mice with a deletion in the first intron of the Collai gene develop age-dependent aortic dissection and rupture. Circ Res 94:83-90.
83. Ramirez F, Dietz HC (2004) Therapy insight: aortic aneurysm and dissection in Marfan's syndrome. Nat Clin Pract 1:31-36.
84. Ridker PM, Hennekens CH, Cerskus A et al. (1994) Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 90:2236-2640.
85. Rucker RB, Tinker D (1977) Structure and metabolism of arterial elastin. Int Rev Exp Pathol 17:1-47.
86. Sariola H, Viljanen T, Luosto R (1986) Histological pattern and changes in extracellular matrix in aortic dissections. J Clin Pathol 39:1074-1081.
87. Schillinger M, Domanovits H, Bayegan K et al. (2002) C-reactive protein and mortality in patients with acute aortic disease. Intensive Care Med 28:740-745.
88. Schlatmann TJ, Becker AE (1977) Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol 39:13-20.
89. Schlatmann TJ, Becker AE (1977) Pathogenesis of dissecting aneurysm of aorta: comparative histopathologic study of significance of medial changes. Am J Cardiol 39:21-26.
90. Schutgens RE, Ackermark P, Haas FJ et al. (2003) Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation 107:593-597.
91. Segura AM, Luna RE, Horiba K, Stetler-Stevenson WG, McAlister HA, Willerson JT et al. (1998) Immunohisto-chemistry of matrix metalloproteinases and their inhibitors in thoracic aortic valves of patients with Marfan's sin-drome. Circulation 98:11331-11338.
92. Selhub J (1999) Homocysteine metabolism. Ann Rev Nutr 19:217-246.
93. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA (1999) Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104:191-197.
94. Shinohara T, Suzuki K, Okada M et al. (2003) Soluble elastin fragments in serum are elevated in acute aortic dissection. Aterioscler Thromb Vase Biol 23:1839-1844.
95. Smith MW, Dean M, Carrington M et al. (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia growth and development study (HGDS), multicenter AIDS cohort study (MACS), multicenter hemophilia cohort study (MHCS), San Francisco City cohort (SFCC), ALIVE study. Science 277:959-965.
96. Spina M, Garbisa S, Zinnie J et al. (1983) Age-related changes in composition and mechanical properties of the tunica media of the upper thoracic human aorta. Arteriosclerosis 3:64-76.
97. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P (1998) Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 102:576-583.
98. Sundt TM, Mora BN, Moon MR, Bailey MS, Pasque MK, Gay WA Jr (2000) Options for repair of a bicuspid aortic valve and ascending aortic aneurysm. Ann Thorac Surg 69:133.
99. Suzuki T, Katoh H, Watanabe M et al. (1996) Novel biochemical diagnostic method for aortic dissection: results of a prospective study using an immunoassay of smooth muscle myosin heavy chain. Circulation 93:1244-1249.
100. Suzuki T, Katoh H, Kurabayashi M et al. (1997) Biochemical diagnosis of aortic dissection by raised concentration of creatine kinase-BB-isozyme. Lancet 350:784-785.
101. Suzuki T, Katoh H, Nagai R (1999) Biochemical diagnosis of aortic dissection: from bench to bedside. Jpn Heart J 40:527-534.
102. Suzuki T, Katoh H, Tsuchio Yet al. (2000) Diagnostic implications of elevated levels of smooth muscle myosin heavy chain protein in acute aortic dissection: the smooth muscle myosin heavy chain study. Ann Intern Med 133:537-541.
103. Takagi H, Umemoto T (2005) Abdominal aortic aneurysm and autosomal-dominant polycystic kidney disease. Kidney Int 67:376.
104. Takeuchi T, Adachi H, Ohuchida M et al. (2004) A case-control study found that low albumin and smoking were associated with aortic dissection. J Clin Epidemiol 57:386-391.
105. Thompson RW, Lee JK, Curci JA (2000) The pathobiology of abdominal aoric aneurysms. In: Gewertz BL (ed) Surgery of the aorta and its branches. Saunders, Philadelphia, pp 75-106.
106. van der Loo B, Jenni R (2003) Acute aortic sindrome: proposal for a novel classification. Heart 89:928.
107. Vaughan CJ, Casey M, He J, Veugelers M et al. (2001) Identification of a chromosome Ilq23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation 103:2469-2475.
108. Verma S, Szmitko PE, Ridker PM (2005) C-reactive protein comes of age. Nat Clin Pract 2:29-36.
109. Vilacosta I (2001) Acute aortic syndrome. Heart 85:365-368.
110. Vilacosta I (2003) Sindrome aortico agudo. Rev Esp Cardiol 56(Suppl l):29-39.
111. Vilacosta I, San Roman JA, Aragoncillo P et al. (1998) Penetrating atherosclerotic aortic ulcer: documentation by transesophageal echocardiography. J Am Coll Cardiol 32:83-89.
112. von Kodohtsch Y, Schwartz AG, Nienaber CA (2000) Clinical prediction of acute aortic dissection. Arch Inter Med 160:2977-2982.
113. Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 325:1202-1208.
114. Weber T, Hogler S, Auer J et al. (2003) D-dimer in acute aortic dissection. Chest 123:1375-1378.
115. Wegener M, Gorich J, Kramer S, Fleiter T, Tomczak R, Scharrer-Pamler R, Kapfer X, Brambs HJ (2001) Thrombus formation in aortic endografts. J Endovasc Ther 8:372-379.
116. Wilcox RG, von der Lippe G, Olsson CG et al. (1988) Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian study of early thrombolysis (ASSET). Lancet 2:525-530.
117. Wolinsky H, Glagov S (1967) A lamellar unit of aortic medial structure and function in mammals. Circ Res 20:99-111.
118. Yanagisawa M, Hamada Y, Katsuragawa Y et al. (1987) Complete primary structure of vertebrate smooth muscle myosin heavy chain deduced from its complementary DNA sequence. J Mol Biol 198:143-157.
119. Zhao L, Moos MPW, Grabner R et al. (2004) The 5-lipoxy-genase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 10:966-973